Recently, we reported that ApoA1 is expressed in the lung epithelium, that lung ApoA1 levels were reduced in patients with idiopathic pulmonary fibrosis, and intranasal treatment with ApoA1 significantly attenuated experimental bleomycin-induced lung injury and fibrosis [5]. This evidence concerns the gene APOA1 and pulmonary fibrosis.